How OCALIVA Works

Leslie, 58 Joined #TeamOCALIVA in 2017

See how OCALIVA works

Understanding the science behind OCALIVA

OCALIVA® (obeticholic acid) treats primary biliary cholangitis (PBC) differently than ursodiol (also called ursodeoxycholic acid or UDCA).

PBC produces bile acid buildup, which can damage the liver. PBC causes a person’s immune system to attack the bile ducts, creating damage and inflammation, which traps toxic bile acids in the liver.

OCALIVA works in a unique way to reduce toxic bile acid buildup caused by PBC

  • OCALIVA can help you lower your ALP level by reducing bile acid buildup in the liver.
  • OCALIVA works by activating a receptor inside your body (called farnesoid X or FXR).* This helps increase the flow of bile acids out of the liver and reduces exposure to toxic bile acids.

OCALIVA treats PBC differently than ursodiol, working alongside it

  • Ursodiol

    Ursodiol dilutes the bile acid pool by replacing/displacing toxic concentrations of bile acids.

  • OCALIVA

    OCALIVA reduces overall exposure to bile acid in your liver, in 2 targeted ways:

    • Limits the amount of bile acids in your liver
    • Increases the flow of bile acids out of the liver

*Farnesoid X (FXR) is a receptor that’s located in your liver. It is also known as the "bile acid receptor."

OCALIVA, when added to ursodiol, may help lower your ALP more than ursodiol alone

The effectiveness of OCALIVA is based on a study that showed a reduction in the liver enzyme ALP. There is no clinical information currently available to show if patients treated with OCALIVA live longer or if their symptoms improve. There are ongoing studies to find out how OCALIVA works over a longer period of time.

OCALIVA may still be working to lower your ALP even if you continue to experience fatigue and pruritus symptoms.

Always talk to your healthcare team before making any changes to your PBC treatment.

Want to learn more about how OCALIVA works? Your doctor may be able to help.

Choose the discussion guide that best describes you, to help you have the right conversation with your doctor.

Want to learn more about PBC and treating with OCALIVA?

Sign up to get PBC-related news and information, tools, tips, and other materials sent to you.

Indication and Important Safety Information

What is OCALIVA?

OCALIVA is a prescription medicine used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have not responded well enough to UDCA, or alone for adults who cannot tolerate UDCA. It is not known if taking OCALIVA will improve your chance of survival or improve your symptoms of PBC. It is not known if OCALIVA is safe and effective in children.

What is the most important information I should know about OCALIVA?

OCALIVA may cause serious side effects including:

Worsening of liver problems or liver failure, in some cases leading to liver transplant or death, has happened in people with primary biliary cholangitis (PBC) with liver cirrhosis when taking OCALIVA.

Before you start OCALIVA, and during your treatment with OCALIVA, your healthcare provider will do tests to check your liver. These tests will help your healthcare provider decide if it is safe for you to start taking OCALIVA and safe for you to continue taking OCALIVA.

Tell your healthcare provider right away if you have any of the following symptoms of worsening liver problems during treatment with OCALIVA:

  • Swelling of your stomach‑area from a build‑up of fluid; yellowing of your skin or the whites of your eyes; black, tarry, or bloody stools; coughing up or vomiting blood, or your vomit looks like “coffee grounds”; mental changes such as confusion, sleepier than usual or harder to wake up, slurred speech, mood swings, or changes in personality.

Tell your healthcare provider right away if you have any of the following symptoms during treatment with OCALIVA and they are severe or do not go away:

  • Stomach‑area pain; nausea, vomiting, or diarrhea; loss of appetite or weight loss; new or worsening fatigue; weakness; fever and chills; light‑headedness; less frequent urination

Who should not take OCALIVA?

Do not take OCALIVA if you:

  • have PBC with liver cirrhosis with symptoms such as fluid in the stomach‑area or confusion (decompensated liver cirrhosis) or with abnormalities in certain tests that check your liver.
  • have a complete blockage of the bile ducts in your liver or gallbladder.

What are the possible side effects of OCALIVA?

OCALIVA may cause serious side effects, including:

  • See “What is the most important information I should know about OCALIVA?”
  • Severe Itching (pruritus). Itching is a common side effect and can sometimes become severe (intense itching or itching over much of your body). Severe itching can cause discomfort, problems sleeping, and problems doing daily activities and usually needs to be treated. Tell your healthcare provider if you get severe itching or if your itching gets worse.
  • Lower HDL‑C (“good” cholesterol). OCALIVA can lower high levels of HDL‑C. Your healthcare provider will check your cholesterol levels during treatment with OCALIVA.

The most common side effects of OCALIVA include: tiredness; stomach pain and discomfort; rash; joint pain; mouth and throat pain; dizziness; constipation; swelling in your hands, ankles, or feet; fast or irregular heartbeat; fever; changes in how your thyroid gland works; dryness, irritation, redness, crusting or drainage of the skin (eczema).

These are not all the possible side effects of OCALIVA. Call your doctor for medical advice about side effects.

What should I tell my healthcare provider before taking OCALIVA?

Before taking OCALIVA, tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or plan to become pregnant. It is not known if OCALIVA will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if OCALIVA passes into your breastmilk. Talk with your healthcare provider about the best way to feed your baby if you take OCALIVA.

Tell your healthcare provider about all the medicines you take, including prescription and over‑the‑counter medicines, vitamins, and herbal supplements. OCALIVA can affect the way certain medicines work. Certain other medicines may affect the way OCALIVA works.

The risk information provided here is not complete. To learn more, please talk to your healthcare provider.

Please click here for Full Prescribing Information and Medication Guide for OCALIVA.

Available by prescription only.

To report negative side effects of OCALIVA, please contact Intercept Pharmaceuticals, Inc. at 1-844-782-ICPT or you may report to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.